转移性黑色素瘤代谢活性肿瘤体积的半自动测量工作流程
本研究基于64例转移性黑色素瘤患者的基线18F-FDG PET/CT图像,评估多种半自动分割流程测量代谢活性肿瘤体积(MATV)的可靠性与可重复性,并与手动分割比较。结果显示部分半自动方法与手动分割无显著差异,且各方法均可区分总生存期,其中SUV40方法最简便易用。
要点
- 半自动MATV与手动分割相关性R²为0.41至0.85。
- SUV40、SUV40+、MV2+和MV3+与手动分割无显著差异。
- 所有分割方法均可区分高于与低于中位MATV患者的总生存期。
核心结论
- 简单快速的半自动FDG PET分割流程可提供准确且可重复的MATV测量,与手动分割相关性良好。
- SUV40方法最易应用且用户友好,适合在前瞻性多中心研究中用于验证该PET生物标志物。
研究设计与样本
- 研究使用64例经组织学证实为转移性黑色素瘤的成年患者队列。
- 基线18F-FDG PET/CT图像来自EANM Research Limited认证的Siemens Biograph mCT PET/CT系统。
- PET数据采用手动分割、基于梯度的分割以及五种半自动方法分析:41MAX、A50P、SUV40、MV2和MV3,部分方法附加手动病灶添加(后缀「+」)。
- 评估不同分割方法间的相关性及其与总生存期的关联。
主要发现
- 手动分割与半自动分割的MATV相关性从A50P的R²=0.41到SUV40+和MV2+的R²=0.85。
- 手动MATV与SUV40(∆MATV均值±SD 0.08±0.60 mL,P=0.303)、SUV40+(∆MATV -0.10±0.51 mL,P=0.126)、MV2+(∆MATV -0.09±0.62 mL,P=0.252)和MV3+(∆MATV -0.03±0.55 mL,P=0.615)无显著差异。
- Log-rank检验显示所有分割方法中高于与低于中位MATV患者的总生存期差异均有统计学意义,ROC曲线下面积手动分割为0.806,半自动分割介于0.756(41MAX)至0.807(MV3+)。
临床怎么用
- 在转移性黑色素瘤患者中,可采用SUV40等半自动分割流程测量MATV,以减少手动分割耗时。
- 半自动MATV测量可用于前瞻性多中心研究,以验证其作为PET成像生物标志物的临床价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Metabolically active tumour volume (MATV) is a potential quantitative positron emission tomography (PET) imaging biomarker in melanoma. Accumulating data indicate that low MATV may predict increased chance of response to immunotherapy and overall survival. However, metastatic melanoma can present with numerous (small) tumour lesions, making manual tumour segmentation time-consuming. The aim of this study was to evaluate multiple semi-automatic segmentation workflows to determine reliability and reproducibility of MATV measurements in patients with metastatic melanoma. METHODS: An existing cohort of 64 adult patients with histologically proven metastatic melanoma was used in this study. 18F-FDG PET/CT diagnostic baseline images were acquired using a European Association of Nuclear Medicine (EANM) Research Limited-accredited Siemens Biograph mCT PET/CT system (Siemens Healthineers, Knoxville, USA). PET data were analysed using manual, gradient-based segmentation and five different semi-automatic methods: three direct PET image-derived delineations (41MAX, A50P and SUV40) and two based on a majority-vote approach (MV2 and MV3), without and with (suffix '+') manual lesion addition. Correlation between the different segmentation methods and their respective associations with overall survival was assessed. RESULTS: Correlation between the MATVs derived by the manual segmentation and semi-automated tumour segmentations ranged from R2 = 0.41 for A50P to R2 = 0.85 for SUV40+ and MV2+, respectively. Manual MATV segmentation did not differ significantly from the semi-automatic methods SUV40 (∆MATV mean ± SD 0.08 ± 0.60 mL, P = 0.303), SUV40+ (∆MATV - 0.10 ± 0.51 mL, P = 0.126), MV2+ (∆MATV - 0.09 ± 0.62 mL, P = 0.252) and MV3+ (∆MATV - 0.03 ± 0.55 mL, P = 0.615). Log-rank tests showed statistically significant overall survival differences between above and below median MATV patients for all segmentation methods with areas under the ROC curves of 0.806 for manual segmentation and between 0.756 [41MAX] and 0.807 [MV3+] for semi-automatic segmentations. CONCLUSIONS: Simple and fast semi-automated FDG PET segmentation workflows yield accurate and reproducible MATV measurements that correlate well with manual segmentation in metastatic melanoma. The most readily applicable and user-friendly SUV40 method allows feasible MATV measurement in prospective multicentre studies required for validation of this potential PET imaging biomarker for clinical use.
引用
- van Sluis J, de Heer EC, Boellaard M, et al. Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma. Eur J Nucl Med Mol Imaging. 2020. PMID: 33099667. doi:10.1007/s00259-020-05068-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。